World's Best Scientists 2026 revealed!
William U. Shipley

William U. Shipley

D-Index & Metrics

Medicine

D-Index
108
Citations
45110
World Ranking
5982
National Ranking
3197

William U. Shipley publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where William U. Shipley sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 528 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

William U. Shipley D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where William U. Shipley sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

William U. Shipley is affiliated with Harvard University in the United States and has a research focus primarily within the field of Medicine. Their publication record spans several subfields including Pulmonary and Respiratory Medicine, Surgery, Urology, Radiation, and Cancer Research.

The main topics of Shipley's work include Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Prostate Cancer Diagnosis and Treatment, Urinary and Genital Oncology Studies, Urological Disorders and Treatments, Advanced Radiotherapy Techniques, and Cancer, Lipids, and Metabolism.

Frequent coauthors collaborating with Shipley are:

  • Jason A. Efstathiou
  • Howard M. Sandler
  • Felix Y. Feng
  • Anthony L. Zietman
  • Thomas M. Pisansky

Shipley's research has been published extensively in several venues, including:

  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • The Journal of Urology
  • JAMA Oncology
  • European Urology Oncology

Selected recent papers authored or coauthored by Shipley include:

  • "Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis" (2023), published in The Lancet Oncology
  • "Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer" (2021), published in JAMA Oncology
  • "Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer" (2020), published in JAMA Oncology
  • "Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis" (2020), published in Journal of Clinical Oncology
  • "Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials" (2022), published in International Journal of Radiation Oncology*Biology*Physics

Best Publications

  • Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

    Mack Roach;Gerald Hanks;Howard Thames;Paul Schellhammer

  • Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate : A randomized controlled trial

    Anthony L. Zietman;Michelle L. DeSilvio;Jerry D. Slater;Carl J. Rossi

  • Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

    Andy Trotti;Roger Byhardt;Joanne Stetz;Clement Gwede

  • Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

    O Dalesio;H van Tinteren;M Clarke;R Peto

  • Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09

    Anthony L. Zietman;Kyounghwa Bae;Jerry D. Slater;William U. Shipley

  • Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

    Gerald E. Hanks;Thomas F. Pajak;Arthur Porter;David Grignon

  • Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

    M V Pilepich;R Caplan;R W Byhardt;C A Lawton

  • Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer

    Christopher U. Jones;Daniel Hunt;David G. McGowan;Mahul B. Amin

  • Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

    Eric M. Horwitz;Kyounghwa Bae;Gerald E. Hanks;Arthur Porter

  • Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

    Miljenko V. Pilepich;William T. Sause;William U. Shipley;John M. Krall

  • Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

    William U. Shipley;Wendy Seiferheld;Himanshu R. Lukka;Pierre P. Major

  • Phase III Trial of Neoadjuvant Chemotherapy in Patients With Invasive Bladder Cancer Treated With Selective Bladder Preservation by Combined Radiation Therapy and Chemotherapy: Initial Results of Radiation Therapy Oncology Group 89-03

    W.U. Shipley;K.A. Winter;D.S. Kaufman;W.R. Lee

  • Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706

    Colleen A. Lawton;Minhee Won;Miljenko V. Pilepich;Sucha O. Asbell

  • Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

    William U. Shipley;Lynn J. Verhey;John E. Munzenrider;Herman D. Suit

  • Biology and Management of Bladder Cancer

    Derek Raghavan;William U. Shipley;Marc B. Garnick;Pamela J. Russell

  • Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

    William U. Shipley;Howard D. Thames;Howard M. Sandler;Gerald E. Hanks

  • Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

    Jason A. Efstathiou;Daphna Y. Spiegel;William U. Shipley;Niall M. Heney

  • Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

    Raymond H. Mak;Daniel Hunt;William U. Shipley;Jason A. Efstathiou

  • Radiation dose-volume effects of the urinary bladder.

    Akila N. Viswanathan;Ellen D. Yorke;Lawrence B. Marks;Patricia J. Eifel

  • Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer

    W.U Shipley;D.S Kaufman;E Zehr;N.M Heney

Frequent Co-Authors

Anthony L. Zietman
Anthony L. Zietman Harvard University
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Gerald E. Hanks
Gerald E. Hanks Fox Chase Cancer Center
Mack Roach
Mack Roach University of California, San Francisco
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Jeff M. Michalski
Jeff M. Michalski Washington University in St. Louis
Alan Pollack
Alan Pollack University of Miami
Eric M. Horwitz
Eric M. Horwitz Fox Chase Cancer Center
Howard D. Thames
Howard D. Thames The University of Texas MD Anderson Cancer Center
Patrick A. Kupelian
Patrick A. Kupelian University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Those interested in studying Medicine in the USA may also explore related healthcare degrees online for greater flexibility and career advancement. Many top universities now offer cahme accredited online mha programs, helping graduates develop essential management and leadership skills for healthcare settings.

For nurses looking to enhance their qualifications, rn bsn online programs no clinicals allow RNs to earn their Bachelor of Science in Nursing with minimal on-site requirements, making education more accessible.

Those aiming for advanced practice or leadership roles can consider a Doctor of Nursing Practice. Many universities offer dnp online programs that can be completed in less time for motivated students, making it easier to balance education with work. For those seeking a more manageable workload, dnp programs designed for flexibility are also available.

These pathways provide diverse options for advancing your healthcare career without sacrificing your current commitments.

Best Scientists Citing William U. Shipley

Trending Scientists

Recently Published Articles